Are you Overwhelmed with M&A Readiness & Integration Activities?

The Navitas Life Sciences Mergers & Acquisitions Readiness and Integration offering has been designed as a best practice tool for PV staff to ensure that it can be a proactive and collaborative partner in business development while ensuring that patient safety is protected throughout the M&A process.

M&A activities are increasing across the industry, which has led to the following challenges facing PV organizations:

  • Lack of clarity on roles and responsibilities
  • Inconsistent processes and interfaces across legacy systems
  • Minimal product portfolio coordination and oversight
  • Poor integration of databases
  • Resistance to integration or harmonization

Navitas Life Sciences Provides an Integrated Approach Leading to Impactful Results

  • PV System Acquisition Preparedness review
  • Due Diligence information gathering
  • Integration Planning, including Transitional Services Agreements
  • Integration Implementation
  • Back to Business - As - Usual
  • Nets benchmarking data leveraged where applicable

Example deliverables include the following

  • Definition and prioritization of M&A readiness parameters and requirements
  • Development of a PV M&A readiness plan (Playbook) including checklists, RACIs and associated communication and training materials along with integration implementation
  • Acquisition Merger checklist
  • PV Due Diligence checklist
  • Template text for Transitional Service Agreements and Safety Data Exchange Agreements (SDEAs)
  • Integrated and harmonized processes and governance aligned to the post-M&A structure
end-to-end pv optimization


Full E2E PV M&A Readiness Assessment and Integration:

  • Increased preparedness for future M&A
  • Adherence to M&A compliance guidelines
  • An integration/implementation plan that addresses real and potential compliance gaps
  • Organizational (staff) readiness to address the full range of integration issues
  • Better defined product portfolio and integration of databases

Latest News & Articles


Encouraging patient-centric innovation in pharma

Dr Ayaaz Hussain Khan, Global Head Generics, Navitas Life Sciences (a TAKE Solutions...


Barriers Preventing Clinical Trial Software Development

Back in August of 2011 in the Wall Street Journal, Marc Andressen, the...